Genericlicensing.com is starting a revolution for business development within the generic pharmaceutical industry by providing free access to the world’s first searchable database of generic dossiers available for licensing, both approved and in development.
Business development is no longer the preserve of a small number of contacts and ‘old boy’ networks. Genericlicensing.com heralds a new era when all companies can benefit from a directory of key data and have immediate access to a global product pipeline. As a premier source of key decision making information it will also ensure opportunities are now available to a much wider audience; for example, smaller companies and those in emerging economies such as Eastern Europe and Latin America.
“To have access to data normally reserved for big corporations is a massive benefit to our business growth; especially at such a cost-effective price. We can now begin to build a pipeline and establish relationships with new partners we would never have come across without Genericlicensing,” said Rob Davies, Managing Director, Alissa Healthcare.
This product directory is set to create a ‘level playing field’ for developers of all sizes and is anticipated to become the ultimate business tool for generic licensing and contract developments. It has been designed to meet the needs of business development teams providing access to market intelligence, portfolio filing, pipeline building.
"As partnering and licensing continue to take on ever increasing strategic relevance, a service such as this can be invaluable, saving time and resource when searching for candidates," said Lisa Harman, Business Development, Teva.
